C

Cutera
D

CUTR

0.42320
USD
-0.02
(-5.43%)
مغلق
حجم التداول
440
الربح لكل سهم
2
العائد الربحي
-
P/E
-0
حجم السوق
8,542,684
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    A
    -1.400
    (-1.02%)
    135.400 USD
    AMGN
    AMGN
    5.10
    (1.71%)
    303.15 USD
    AMP
    AMP
    -10.08
    (-1.86%)
    530.93 USD
    BDX
    BDX
    -0.590
    (-0.26%)
    227.450 USD
    BMY
    BMY
    0.050
    (0.09%)
    55.840 USD
    BSX
    BSX
    -0.840
    (-0.80%)
    104.480 USD
    C
    CAH
    -0.340
    (-0.27%)
    127.080 USD
    CI
    CI
    0.07
    (0.02%)
    299.89 USD
    COO
    COO
    -0.180
    (-0.20%)
    88.490 USD
    CVS
    CVS
    -1.595
    (-2.45%)
    63.495 USD
    D
    DGX
    0.115
    (0.07%)
    172.290 USD
    EW
    EW
    -1.380
    (-1.85%)
    73.300 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    HUM
    HUM
    -15.35
    (-5.66%)
    255.95 USD
    JNJ
    JNJ
    2.680
    (1.68%)
    162.370 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    MRK
    MRK
    1.820
    (2.08%)
    89.500 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    ZBH
    ZBH
    1.250
    (1.21%)
    104.890 USD
    المزيد
الأخبار
المقالات

العنوان: Cutera

القطاع: Healthcare
الصناعة: Medical Devices
Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo amongothers. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.